
Sign up to save your podcasts
Or


Tiffany and Michael Kors report earnings as their stocks head in different directions. Pharmaceutical giant Novartis gets to work on a “robotic pill”. Plus, Motley Fool Funds analyst Bill Barker shares some money insights from his recent trip to England.
By The Motley Fool4.7
16041,604 ratings
Tiffany and Michael Kors report earnings as their stocks head in different directions. Pharmaceutical giant Novartis gets to work on a “robotic pill”. Plus, Motley Fool Funds analyst Bill Barker shares some money insights from his recent trip to England.

3,221 Listeners

1,487 Listeners

808 Listeners

948 Listeners

521 Listeners

1,167 Listeners

2,184 Listeners

825 Listeners

1,421 Listeners

1,037 Listeners

9,717 Listeners

195 Listeners

826 Listeners

86 Listeners

585 Listeners

1,036 Listeners

53 Listeners